OpenAlex
PricingAboutJobs
Log inGet started
Work

An Open-Label, Dose-Ranging Study of Atomoxetine in Children with Attention Deficit Hyperactivity Disorder

HTML

Year: 2001
Type: article
Study design: Clinical Trial
Source: Journal of Child and Adolescent Psychopharmacology
DOI: 10.1089/10445460152595577
Authors: Thomas Spencer, Joseph Biederman, John Heiligenstein, Timothy Wilens, Douglas Faries, Jefferson Prince, Stephen V. Faraone, Jackie Rea, Jennifer Witcher, Stephanie Zervas
Institution: Massachusetts General Hospital
Language: English

Topic: Attention Deficit Hyperactivity Disorder
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: atomoxetine, attention deficit hyperactivity disorder, children with ADHD, noradrenergic reuptake inhibitors, dose titration, drug tolerability, ADHD symptom reduction, ADHD Rating Scale-IV, cardiovascular parameters
SDG: Good health and well-being

Open Access status: closed

Funders: Eli Lilly and Company, National Institutes of Health, National Institute of Mental Health
Award: CONTROLLED STUDY OF METHYLPHENIDATE IN ADULTS WITH ADHD
OpenAlex ID: W2083338868
FWCI: 7.031
Cites: 36
Cited by: 159
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security